MiR-146a mimic attenuates murine allergic rhinitis by downregulating TLR4/TRAF6/NF-κB pathway

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Allergic rhinitis (AR) is a common inflammatory condition.
• The role of microRNAs in AR pathogenesis is an area of active research.
• miR-146a is a key regulator in immune and inflammatory responses.

Purpose of the Study:

• To investigate the therapeutic potential of microRNA (miR)-146a in a mouse model of allergic rhinitis (AR).
• To explore the underlying molecular mechanisms of miR-146a's action in AR.

Main Methods:

• Female BALB/c mice were induced with allergic rhinitis using ovalbumin (OVA).
• miR-146a mimic was administered intranasally to AR mice.
• Key immunological and molecular markers were assessed, including IgE levels, inflammatory cytokines, inflammatory cell infiltration, and the TLR4/TRAF6/NF-κB signaling pathway.

Main Results:

• miR-146a expression was significantly decreased in the nasal mucosa of AR mice.
• Intranasal administration of miR-146a mimic attenuated AR symptoms like sneezing and nasal rubbing.
• miR-146a mimic reduced OVA-specific IgE, inflammatory cytokines, inflammatory cell infiltration, and modulated T-helper 2 responses.
• miR-146a mimic inhibited the expression of proteins in the TLR4/TRAF6/NF-κB signaling pathway.

Conclusions:

• miR-146a demonstrates significant therapeutic potential for allergic rhinitis.
• The anti-inflammatory effects of miR-146a in AR are mediated, at least in part, by the inhibition of the TLR4/TRAF6/NF-κB signaling pathway.